Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Avanos Medical, Inc.

Avanos Medical, Inc. (AVNS) Stock Overview

Explore Avanos Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AVNS●NYSE
HealthcareMedical - Devices
$24.99
$0.010(0.04%)
U.S. Market opens in 3h 5m

Avanos Medical, Inc. (AVNS)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-16.65
EPS (TTM)$0.90
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$23.95
3 Months$33.37
1 Year Target$19.29

AVNS Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Avanos Medical, Inc. (NYSE: AVNS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Avanos Medical, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AVNS on the NYSE shows an RSI of 57.05, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $19.29 for the NYSE listing.

Key metrics behind Avanos Medical, Inc.'s NYSE-traded stock include a P/E ratio of -16.65 and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AVNS on the NYSE.

Price Performance (NYSE: AVNS)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.24%
3-Month Change
1.09%
6-Month Change
67.72%
Year-to-Date (YTD) Change
122.53%
1-Year Change
132.47%
3-Year Change
11.66%
5-Year Change
-27.02%
All-Time (Max) Change
-39.05%

Contact Information

https://avanos.com
844 428 2667
5405 Windward Parkway, Alpharetta, GA, 30004

Company Facts

22,870 Employees
IPO DateOct 21, 2014
CountryUS

Frequently Asked Questions